Newsletter | January 21, 2023

01.21.23 -- Release Specs For Plasmid MCBs, Plasmid DNA
 
Featured Editorial
Release Specifications For Plasmid MCBs, Plasmid DNA
By BioPhorum
Leveraging Human Genetics To Advance Cell Therapies For Treatment Of Blood Cancers
By Abhinav Dhall, Carolyn Wills, Nathan Jorgensen, Tirtha Chakraborty, and John Lydeard at Vor Biopharma
The Regulatory Labyrinth Of Stem Cell Treatments
By Chad Landmon and Gulrukh Haroon
Defining Translational Research
Cytiva
Industry Insights
FDA INTERACT Meetings: Early Interactions For Cell And Gene Therapy Sponsors
By Annette F. Arlinghaus and Stacey A. Ayres, Ph.D.
L-Glutamine Dipeptide To Improve Cell Culture Performance
By Dr. Martin Schilling
Early Plasmid Optimization For Long-Term Commercial Success
By Kristin Heller and Andy Moreo
Cold Chain Durability Of Fluoropolymer Bags
By Joe Cintavey and Meghan Meeuwissen
Analytical Techniques For Addressing Viral Vector Purification Challenges
Kymanox Corporation
QualTrak Real-Time PCR And Digital PCR Ecosystem For Streamlined Biologics Development
Applied Biosystems by Thermo Fisher Scientific, qPCR
Holographic Imaging Of Insect Cell Cultures
Ovizio Imaging Systems
Operationalizing Disclosure Intelligence For Go-To-Market Success
Citeline
Identify And Select Optimal CAR T Phenotypes
Berkeley Lights
Media Adaptation For Suspension Cells
Mirus Bio LLC
Introduction To Tangential Flow Filtration
Pall Corporation
A Guide To Finding The Right Cell Culture Media For Your Bioprocesses
Sartorius
The Road To Reality For Allogeneic Cell Therapy
Cytiva
Promises And Risks Of Allogeneic Therapies
By Shabnam Mehta, Sankalp Sethi, Curt Kugel, and Lexie Cornely
Quality By Design (QbD) For Adeno-Associated Virus (AAV)
By Paul Cashen and Britta Manser
Evaluating A Flexible LC Platform For Biopharmaceutical Labs
By Jacob Kellett, Brooke M. Koshel, Hua Yang, Robert E. Birdsall, Stephan M. Koza, and Ying Qing Yu
Streamlining Cell Therapy Delivery With Efficiency-Led Design
Cytiva
Droplet Digital PCR For Safe And Effective CAR T Cell Therapies
Mark White
Cleanroom Design & Installation
AES Clean Technology, Inc.
Ensuring Viral Vector Supply For Gene Therapies
MilliporeSigma
Shortening Development And Approval Timelines For Novel Medicinal Products
Veristat, Inc.
Go/No Go Decisions Based On Early Phase Oncology Trials
Novotech
Automating Ancillary Processes: Closing The New Bottleneck In Cell And Gene Therapy Manufacturing
Invetech
Confronting Scalability With Autologous Therapies
Catalent
Accelerating Readiness In Biotech: From Project Mode To Operations
CAI
Handle With Care: Ensuring LNP Lipid Quality For Better Genetic Medicines
SCIEX
3 Important Developments In Aseptic Connection Technology
CPC